Category Archives: Spinal Cord Injury Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a drug delivery company with a focus on groundbreaking technologies for thetreatment of spinal cord injuries(SCI) and neurotrauma conditions, today announced that Gregory D. Perry has been appointed as interim CFO, commencing September 23, 2013. Mr. Perry was most recently the Executive Vice President and CFO of Immunogen, Inc. Prior to joining Immunogen, Mr. Perry served as CFO of Elixir Pharmaceuticals, Inc. from 2007 to 2009. Prior to Elixir, he was CFO of Domantis Ltd., which was acquired by GlaxoSmithKline in 2006. Previously, Mr. Perry was Senior Vice President and CFO of Transkaryotic Therapies, Inc. until its acquisition by Shire plc in 2005. Mr. Perry is currently a member of the Board of Directors of Advanced Cell Technology, Inc. "We are excited tobring on boarda CFO with the integrity, talent and experience of Greg Perry, said Mike Astrue, the interim CEO of InVivo. "His breadth of experience can add value to InVivo in a variety of ways." About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments for serious diseases and conditions, including improving function in individuals paralyzed as a result of traumatic … Continue reading →

WEST HARTFORD, Conn. (WTNH) -- A drug free option for pain is now available in Connecticut. A nerve injury can be extremely painful. At times medication and other treatments can not bring relief. Now there's a new option that's non-invasive and drug free. Michelle Lyster tore a tendon in her right ankle, but after surgery she developed reflex sympathetic dystrophy. "Which causes severe burning pain, hypersensitivity," Lyster said. Doctors could do little for her excruciating pain. "I've been on a cane or crutches for the entire six years," Lyster said. Now a new electrical stimulation therapy offered at the Pain Treatment Center at Hartford Hospital is easing much of Lyster's pain. "The sensitivity is really down," she said. Dr. Jonathan Kost says it sends a no-pain message through electrodes. "Electrodes are essentially placed in the vicinity of the nerve injury," said Dr. Kost. "This new device resets the pain signal of how it's being sent eventually into the spinal cord and up to the brain as not being as painful as it was prior to the treatment." "It feels like a bee stinging," Lyster said, "but it's not painful and then it gets to a point where it's more of … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a drug delivery company with a focus on groundbreaking technologies for thetreatment of spinal cord injuries(SCI) and neurotrauma conditions, today announced that current Board member John A. McCarthy, Jr. has been appointed as non-executive Chairman of the Board. In addition, Board member Kenneth DiPietro has been appointed as a member of the Boards Audit Committee. In addition, the acting CFO, Sean F. Moran, has resigned effectively immediately. The Company is actively engaged in a search for a replacement. In the meantime, the interim CEO, Michael J. Astrue, will serve as principal financial officer until a replacement is named. Mr. McCarthy is currently the Chief Executive Officer at CryoXtract Instruments, and has been on InVivos Board of Directors since April 2013. Mr. DiPietro currently serves as Executive Vice President, Human Resources at Biogen Idec, and joined InVivos Board in December 2012. As a result of Mr. Morans departure, InVivo will not present at the 15th Annual Rodman and Renshaw Healthcare Conference to be held on Tuesday, September 10, 2013 at the Millennium Broadway Hotel in New York City. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform … Continue reading →

Public release date: 9-Sep-2013 [ | E-mail | Share ] Contact: Meng Zhao eic@nrren.org 86-138-049-98773 Neural Regeneration Research Following spinal cord injury, astrocyte proliferation and scar formation are the main factors inhibiting the regeneration and growth of spinal cord axons, leading to motor and sensory function loss below the level of spinal cord injury. Cell transplantation, bioengineering technology, drugs and other methods can reduce voids of injured spinal cord and suppress glial scar formation, but clinical application results show these methods used alone have no obvious effects. Liang Wu and colleagues from Capital Medical University used rat models of T8 spinal cord contusion, which were subjected to combined transplantation of bone morphogenetic protein-4-induced glial-restricted precursor-derived astrocytes and human recombinant decorin transplantation. This combined transplantation promoted axonal regeneration and growth of injured motor and sensory neurons by inhibiting astrocyte proliferation and glial scar formation, with astrocytes forming a linear arrangement in the contused spinal cord, thus providing axonal regeneration channels. This combined transplantation provides a potential new therapy for experimental research and clinical transformation for the repair of spinal cord injury. These findings were published in the Neural Regeneration Research (Vol. 8, No. 24, 2013). ### Article: " Combined transplantation of … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for thetreatment of spinal cord injuries(SCI) and neurotrauma conditions, today announced that Acting Chief Financial Officer Sean Moran is scheduled to present to investors at the 15th Annual Rodman and Renshaw Healthcare Conference to be held September 8-10, 2013 at the Millennium Broadway Hotel in New York City. The presentation is scheduled for Tuesday, September 10 at 2:25 pm ET in Room 704 on the 7th Floor. A live webcast will be available at http://wsw.com/webcast/rrshq23/NVIV. Additional information about the 15th Annual Rodman and Renshaw Healthcare Conference can be found at http://www.rodm.com/conferences. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments for serious diseases and conditions, including improving function in individuals paralyzed as a result of traumatic spinal cord injury. The Company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. In 2011, the Company earned the prestigious David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal … Continue reading →

ROCKVILLE, Md., Sept. 3, 2013 /PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 15th annual Rodman & Renshaw Healthcare Conference on Tuesday, September 10, at 11:40 a.m. EST, in Room 7.03, 7th Floor, of the Millennium Broadway Hotel in New York City. Garr will provide an overview of the company's upcoming NSI-566 cell therapy clinical trials, including ALS Phase II, ischemic stroke Phase I/II, and chronic and acute spinal cord injury Phase I. He will also provide an update on the novel neurogenic small molecule drug, NSI-189, Phase Ib clinical trial in major depressive disorder. To view the live webcast, visit Neuralstem's Investor Center at http://www.neuralstem.com, or: http://wsw.com/webcast/rrshq23/CUR. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) The 15th annual Rodman & Renshaw Healthcare Conference is being held at the Millennium Broadway Hotel in New York City, September 8-10. For more information, see: http://www.meetmax.com/sched/event_20174/~public/conference_home.html?event_id=20174 About Neuralstem Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed an FDA-approved Phase I safety clinical trial for amyotrophic … Continue reading →

Newswise BOSTON Beth Israel Deaconess Medical Center (BIDMC) has been awarded a grant from the National Institutes of Health (NIH) to investigate the use of a new noninvasive neurophysiologic intervention for the treatment of patients with spinal cord injuries. Alvaro Pascual-Leone, MD, PhD, Director of BIDMCs Berenson-Allen Center for Noninvasive Brain Stimulation, will serve as Co-Principal Investigator of the two-year $525,824 grant, together with Dylan Edwards, PhD, of the Burke Medical Research Institute/Weill Cornell Medical College. Mar Cortes, MD, will be a key investigator overseeing the protocol implementation and bridging the two study sties at BIDMC and Burke. Spinal Associative Stimulation (SAS) is a noninvasive therapy that combines transcranial magnetic stimulation (TMS) and peripheral nerve stimulation to help bolster rehabilitation in patients with incomplete spinal cord injuries. SAS works by engaging and strengthening residual undamaged spinal-cord fibers present in many of even the most severely injured patients to increase voluntary activation of weakened muscles. This is a very exciting study, says Pascual-Leone. We need new methods to enhance recovery in patients with spinal-cord injury and this funded study is critical to increase our understanding of SAS, which harnesses nervous system plasticity to promote clinical recovery. Ultimately, to maximally help patients, … Continue reading →

David Triplow damaged his spinal cord during his first rugby match for his regiment, the Royal Logistics Corp at Deep Cut Barracks in Surrey He was paralysed from the waist down for several weeks Mr Triplow underwent a nine-hour operation to pin his spine back together Battled back to health so he could walk with his girlfriend down the aisle He is now training to take part in the Great North Run next month By Emma Innes PUBLISHED: 11:34 EST, 26 August 2013 | UPDATED: 12:15 EST, 26 August 2013 27 shares 13 View comments A soldier who was told he might never walk again after he broke his neck is set to take part in the Great North Run. David Triplow suffered a devastating injury while playing his first game of rugby for his regiment, but has amazed doctors by battling back to health. The 32-year-old, of Whitburn, South Tyneside, shattered his neck but has since recovered sufficiently to walk his girlfriend, Michelle, 28, down the aisle. David Triplow, 32, broke his neck and damaged his spinal cord while playing his first game of rugby for his regiment. He has amazed doctors by battling back to health and is … Continue reading →

LAUSANNE, Switzerland, August 29, 2013 /PRNewswire/ -- Debiopharm Group (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs targeting unmet medical needs as well as companion diagnostics, presents today the 'Debiopharm Group Life Sciences Award 2013' to Professor Grgoire Courtine for his outstanding research on 'Restoring Motor Functions after Spinal Cord Injury'. The two 'Junior Debiopharm Group Life Sciences Awards 2013'areattributed to Dr Leanne Li for her research on cancer and the nervous system and to Dr Stphane Baudoin for his work on the heterogeneity of psychiatric disorders. Organized by the Brain Mind Institute (BMI), the ceremony will take place today at the EPFL (Ecole polytechnique fdrale de Lausanne) during the Annual EPFL SV- Life Science Symposium 2013. The theme of this year's symposium is 'Motor Control - from neural circuits and diseases to neuroprosthetics.' This year's award honors Prof. Grgoire Courtine from the International Paraplegic Foundation (IRP) Chair in Spinal Cord Repair, the Center for Neuroprosthetic and Brain Mind Institute, EPFL and adjunct Professor from the University Hospital of Vaud (CHUV). His research on restoring motor function in severely paralyzed people won him the amount of CHF 50'000 of which CHF 40'000 are made … Continue reading →

Las Vegas, NV (PRWEB) August 26, 2013 The premier pain management clinic in Henderson and Las Vegas, Innovative Pain Care, is now offering cutting edge treatment for chronic low back and neck pain. Spinal cord stimulator implants offer an excellent chance of obtaining relief for pain, with many patients able to get back to work and decrease pain medications necessary. Call (702) 323-0553 for more information and scheduling to find out more. According to the Institute of Medicine, over 100 million Americans suffer from chronic pain. This is about one third of the population, and unfortunately a number of individuals have already tried significant treatment. Innovative Pain Care Center has a Double Board Certified Las Vegas pain management doctor, Dr. Daniel Burkhead, who is highly skilled in spinal cord stimulator implants. For patients dealing with failed back surgery syndrome or neck pain that has not responded to other treatments, spinal cord stimulation may provide immense relief. The clinics have two locations, one in Las Vegas and the other in Henderson. These implants are often able to mask a person's pain and replace it with a tingling sensation. For a person who has no further surgical option, the implant may be … Continue reading →